Are these numbers correct?
US FSGS market alone
80000 patients
$US7000/month
And, if DMX-200 got just 10% of that market...
That’s $US56M per MONTH
Conversion ~0.7, SO $AU80M per MONTH
$AU960M per YEAR...?
And that’s just FSGS...
I’m not prepared to look at the diabetic market.
Ann: CEO's Address to Shareholders, page-3
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
-0.035(6.42%) |
Mkt cap ! $280.3M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 54.0¢ | 50.0¢ | $1.454M | 2.822M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 544899 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 104681 | 4 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |